0001209191-14-027652.txt : 20140415
0001209191-14-027652.hdr.sgml : 20140415
20140415181932
ACCESSION NUMBER: 0001209191-14-027652
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140411
FILED AS OF DATE: 20140415
DATE AS OF CHANGE: 20140415
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Opko Health, Inc.
CENTRAL INDEX KEY: 0000944809
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 752402409
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4400 BISCAYNE BLVD.
STREET 2: SUITE 900
CITY: MIAMI
STATE: FL
ZIP: 33137
BUSINESS PHONE: 305-575-6015
MAIL ADDRESS:
STREET 1: 4400 BISCAYNE BLVD.
STREET 2: SUITE 900
CITY: MIAMI
STATE: FL
ZIP: 33137
FORMER COMPANY:
FORMER CONFORMED NAME: eXegenics Inc
DATE OF NAME CHANGE: 20040505
FORMER COMPANY:
FORMER CONFORMED NAME: EXEGENICS INC
DATE OF NAME CHANGE: 20011114
FORMER COMPANY:
FORMER CONFORMED NAME: CYTOCLONAL PHARMACEUTICS INC /DE
DATE OF NAME CHANGE: 19950503
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rubin Steven D
CENTRAL INDEX KEY: 0001381874
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33528
FILM NUMBER: 14766125
MAIL ADDRESS:
STREET 1: 4400 BISCAYNE BOULEVARD, 15TH FLOOR
CITY: MIAMI
STATE: FL
ZIP: 33137
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-04-11
0
0000944809
Opko Health, Inc.
OPK
0001381874
Rubin Steven D
OPKO HEALTH, INC.
4400 BISCAYNE BLVD.
MIAMI
FL
33137
1
1
0
0
Executive VP-Administration
Common Stock
2014-04-11
4
M
0
500000
4.88
A
4769855
D
Common Stock
2014-04-11
4
M
0
200000
1.65
A
4969855
D
Common Stock
2014-04-11
4
F
0
312289
8.87
D
4657566
D
Common Stock
2014-04-14
4
S
0
100000
8.577
D
4557566
D
Common Stock
2014-04-15
4
S
0
79300
8.1036
D
4478266
D
Common Stock
15490546
I
See Footnote
Stock Option (Right to Buy)
4.88
2014-04-11
4
M
0
500000
0.00
D
2014-05-03
Common Stock
500000
0
D
Stock Option (Right to Buy)
1.65
2014-04-11
4
M
0
200000
0.00
D
2015-04-28
Common Stock
200000
0
D
Stock Option (Right to Buy)
8.37
2014-04-14
4
A
0
350000
0.00
A
2024-04-13
Common Stock
350000
350000
D
Represents number of shares withheld by the Company at the direction of the reporting person for the payment of exercise price in connection with the exercise of stock options. The reporting person has retained the net number of shares issued upon the exercise of the option (387,711 shares).
Closing market price of the Company's common stock on the transaction date.
The shares sold on April 14 and 15, 2014 were sold to pay/satisfy federal and/or state tax withholding in connection with a stock option exercise on April 11, 2014. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.20 to $8.82, inclusive. The reporting person undertakes to provide to OPKO Health, Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.00 to $8.40, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (5) to this Form 4.
These securities are owned directly by The Frost Group, LLC. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
The options were granted on May 3, 2007 and vested in four equal installments beginning on May 3, 2008.
The options were granted on April 28, 2008 and vested in four equal installments beginning on April 28, 2009.
This option will vest in four equal annual installments beginning April 14, 2015.
Steve D. Rubin
2014-04-15